Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients

BACKGROUND: Coagulopathies are a major class among COVID-19 associated complications. Although anticoagulants such as unfractionated Heparin and Enoxaparin are both being used for therapeutic mitigation of COVID associated coagulopathy (CAC), differences in their clinical outcomes remain to be inves...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:EClinicalMedicine
Main Authors: Pawlowski, Colin, Venkatakrishnan, AJ, Kirkup, Christian, Berner, Gabriela, Puranik, Arjun, O'Horo, John C., Badley, Andrew D., Soundararajan, Venky
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2021
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941023/
https://ncbi.nlm.nih.gov/pubmed/33718845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100774
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים